JP2019516789A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019516789A5 JP2019516789A5 JP2019510578A JP2019510578A JP2019516789A5 JP 2019516789 A5 JP2019516789 A5 JP 2019516789A5 JP 2019510578 A JP2019510578 A JP 2019510578A JP 2019510578 A JP2019510578 A JP 2019510578A JP 2019516789 A5 JP2019516789 A5 JP 2019516789A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- fulvestrant
- international
- publication
- international publication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021118471A JP7312523B2 (ja) | 2016-05-06 | 2021-07-19 | フルベストラント配合物およびその使用方法 |
| JP2023086732A JP2023109959A (ja) | 2016-05-06 | 2023-05-26 | フルベストラント配合物およびその使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662332842P | 2016-05-06 | 2016-05-06 | |
| US62/332,842 | 2016-05-06 | ||
| US201662420555P | 2016-11-10 | 2016-11-10 | |
| US62/420,555 | 2016-11-10 | ||
| PCT/US2017/031376 WO2017193048A1 (en) | 2016-05-06 | 2017-05-05 | Fulvestrant formulations and methods of their use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021118471A Division JP7312523B2 (ja) | 2016-05-06 | 2021-07-19 | フルベストラント配合物およびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019516789A JP2019516789A (ja) | 2019-06-20 |
| JP2019516789A5 true JP2019516789A5 (OSRAM) | 2020-04-30 |
Family
ID=58709642
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019510578A Pending JP2019516789A (ja) | 2016-05-06 | 2017-05-05 | フルベストラント配合物およびその使用方法 |
| JP2021118471A Active JP7312523B2 (ja) | 2016-05-06 | 2021-07-19 | フルベストラント配合物およびその使用方法 |
| JP2023086732A Pending JP2023109959A (ja) | 2016-05-06 | 2023-05-26 | フルベストラント配合物およびその使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021118471A Active JP7312523B2 (ja) | 2016-05-06 | 2021-07-19 | フルベストラント配合物およびその使用方法 |
| JP2023086732A Pending JP2023109959A (ja) | 2016-05-06 | 2023-05-26 | フルベストラント配合物およびその使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20190134059A1 (OSRAM) |
| EP (1) | EP3452011A1 (OSRAM) |
| JP (3) | JP2019516789A (OSRAM) |
| KR (1) | KR102438425B1 (OSRAM) |
| CN (1) | CN109310621A (OSRAM) |
| AU (2) | AU2017261321B2 (OSRAM) |
| CA (1) | CA3022834A1 (OSRAM) |
| CO (1) | CO2018013257A2 (OSRAM) |
| IL (2) | IL285928B2 (OSRAM) |
| MA (1) | MA44862A (OSRAM) |
| MX (2) | MX2018013414A (OSRAM) |
| MY (1) | MY205661A (OSRAM) |
| UA (1) | UA125514C2 (OSRAM) |
| WO (1) | WO2017193048A1 (OSRAM) |
| ZA (1) | ZA201807031B (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11590077B2 (en) | 2016-05-06 | 2023-02-28 | Eagle Pharmaceuticals, Inc. | Fulvestrant formulations and methods of their use |
| CN111479556B (zh) * | 2017-11-08 | 2023-09-01 | 伊格尔制药公司 | 氟维司群制剂及其使用方法 |
| CN113260353B (zh) * | 2019-12-11 | 2024-11-29 | 上海云晟研新生物科技有限公司 | 氟维司群药物组合物、其制备方法及应用 |
| CN113694017B (zh) * | 2020-05-11 | 2024-04-02 | 鲁南制药集团股份有限公司 | 一种氟维司群注射制剂及其制备方法 |
| WO2022100750A1 (zh) * | 2020-11-16 | 2022-05-19 | 北京厚燊维康科技有限责任公司 | 可用于光动力治疗或诊断的制剂 |
| CN120284882A (zh) * | 2020-12-10 | 2025-07-11 | 上海云晟研新生物科技有限公司 | 氟维司群药物组合物、其制备方法及应用 |
| JP2024545690A (ja) * | 2021-12-20 | 2024-12-10 | サムヤン、ホールディングス、コーポレーション | 溶解度が改善されたフルベストラントの医薬組成物及びその製造方法 |
| KR20240105964A (ko) * | 2022-12-29 | 2024-07-08 | 주식회사 삼양홀딩스 | 약동학적 특성이 우수한 풀베스트란트의 약학 조성물 및 그 제조 방법 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8853260B2 (en) * | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| GB0000313D0 (en) * | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
| EP1282401A2 (en) | 2000-05-15 | 2003-02-12 | PHARMACIA & UPJOHN S.p.A. | Stabilized steroidal suspension |
| US6495534B2 (en) | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
| GB0116619D0 (en) * | 2001-07-07 | 2001-08-29 | Astrazeneca Ab | Formulation |
| HUP0400115A3 (en) * | 2001-07-07 | 2005-11-28 | Astrazeneca Ab | Pharmaceutical composition for the intramuscular administration of fulvestrant |
| JP2003298516A (ja) | 2002-03-29 | 2003-10-17 | Fujitsu Ltd | 波長分散補償装置 |
| PL1778187T3 (pl) | 2004-08-04 | 2012-09-28 | Camurus Ab | Kompozycje tworzące nielamelarne dyspersje |
| EP2484344B1 (en) | 2005-05-09 | 2016-02-10 | Biosphere Medical, S.A. | Compositions and methods of using microspheres and non-ionic contrast agents |
| WO2007069272A2 (en) | 2005-10-21 | 2007-06-21 | Panacea Biotec Limited | Pharmaceutical composition comprising at least one anticancer drug and at least one polymer |
| US8158152B2 (en) | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| CN101108168B (zh) * | 2007-08-03 | 2010-12-08 | 西安力邦医药科技有限责任公司 | 一种氟维司群缓释微球的制备方法 |
| US9254268B2 (en) | 2007-09-25 | 2016-02-09 | Solubest Ltd. | Compositions comprising lipophilic active compounds and method for their preparation |
| CA2716576A1 (en) | 2008-03-07 | 2009-09-11 | Nageswara R. Palepu | Fulvestrant formulations |
| TW201016220A (en) * | 2008-10-31 | 2010-05-01 | Scinopharm Taiwan Ltd | Micronization form of 7α-[9-(4,4,5,5,5-pentafluoropentylsufinyl)nonyl]estra-1,3,5(10)-triene-3,17β-diol and process for the preparation thereof |
| KR20120052937A (ko) | 2009-06-18 | 2012-05-24 | 아보트 러보러터리즈 | 안정한 나노입자형 약물 현탁액 |
| WO2011022861A1 (zh) | 2009-08-31 | 2011-03-03 | 西安力邦医药科技有限责任公司 | 氟维司群纳米球/微球及其制备方法和用途 |
| WO2011011978A1 (zh) * | 2009-07-31 | 2011-02-03 | 西安力邦医药科技有限责任公司 | 微球药物载体、其制备方法、组合物及应用 |
| WO2012021791A2 (en) | 2010-08-13 | 2012-02-16 | Scidose Llc | Aqueous formulation with improved stability |
| EP2616078B1 (en) * | 2010-09-16 | 2019-12-25 | Shimoda Biotech (Pty) Ltd | Fulvestrant compositions and methods of use |
| EP2468258A1 (en) | 2010-12-22 | 2012-06-27 | LEK Pharmaceuticals d.d. | Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient |
| CN103429267B (zh) | 2011-01-09 | 2016-05-04 | Anp科技公司 | 疏水分子诱导的支化聚合物集合体及其用途 |
| CA2836831C (en) * | 2011-05-20 | 2015-06-02 | Capital, Business Y Gestion De Finanzas S.L. | Pharmaceutical composition |
| CN102915088A (zh) | 2011-08-03 | 2013-02-06 | 鸿富锦精密工业（深圳）有限公司 | 资料存储器固定装置 |
| US11179468B2 (en) * | 2012-04-09 | 2021-11-23 | Eagle Pharmaceuticals, Inc. | Fulvestrant formulations |
| CA2869377C (en) | 2012-04-09 | 2022-11-08 | Scidose, Llc | Fulvestrant formulations |
| NZ702244A (en) | 2012-06-08 | 2017-06-30 | Hoffmann La Roche | Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer |
| CN104337761B (zh) * | 2013-08-07 | 2019-03-26 | 江苏豪森药业集团有限公司 | 氟维司群药物组合物 |
| JP2016529308A (ja) * | 2013-09-06 | 2016-09-23 | サラー ウッディン アハメド， | フルベストラント組成物 |
| US20160287601A1 (en) * | 2013-10-03 | 2016-10-06 | Millennium Pharmaceuticals, Inc. | Enhanced treatment regimens using pi3k inhibitors |
| HUP1300646A2 (en) | 2013-11-12 | 2015-05-28 | Druggability Technologies Ip Holdco Jersey Ltd | Complexes of fulvestrant and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| PT107433B (pt) | 2014-01-28 | 2018-12-04 | Hovione Farm S A | Processo de redução e controlo do tamanho de partícula |
| US9271990B2 (en) | 2014-02-14 | 2016-03-01 | Fresenius Kabi Usa, Llc | Fulvestrant formulations |
| JP6235755B2 (ja) | 2014-07-02 | 2017-11-22 | ザ リサーチ ファウンデイション フォー ザ ステイト ユニバーシティー オブ ニューヨーク | 高いカーゴ対サーファクタント比を有するサーファクタント除去ミセル組成物 |
| WO2015018380A2 (en) | 2014-07-03 | 2015-02-12 | Cspc Zhongqi Pharmaceutical Technology(Shijiazhuang)Co., Ltd. | Therapeutic nanoparticles and the preparation methods thereof |
-
2017
- 2017-05-04 IL IL285928A patent/IL285928B2/en unknown
- 2017-05-05 MX MX2018013414A patent/MX2018013414A/es unknown
- 2017-05-05 MY MYPI2018703903A patent/MY205661A/en unknown
- 2017-05-05 KR KR1020187034942A patent/KR102438425B1/ko active Active
- 2017-05-05 JP JP2019510578A patent/JP2019516789A/ja active Pending
- 2017-05-05 AU AU2017261321A patent/AU2017261321B2/en active Active
- 2017-05-05 MA MA044862A patent/MA44862A/fr unknown
- 2017-05-05 UA UAA201812019A patent/UA125514C2/uk unknown
- 2017-05-05 US US16/099,265 patent/US20190134059A1/en not_active Abandoned
- 2017-05-05 WO PCT/US2017/031376 patent/WO2017193048A1/en not_active Ceased
- 2017-05-05 EP EP17723902.7A patent/EP3452011A1/en active Pending
- 2017-05-05 CN CN201780027809.5A patent/CN109310621A/zh active Pending
- 2017-05-05 CA CA3022834A patent/CA3022834A1/en active Pending
-
2018
- 2018-10-18 IL IL262465A patent/IL262465A/en unknown
- 2018-10-22 ZA ZA2018/07031A patent/ZA201807031B/en unknown
- 2018-11-01 MX MX2022013199A patent/MX2022013199A/es unknown
- 2018-12-06 CO CONC2018/0013257A patent/CO2018013257A2/es unknown
-
2021
- 2021-07-19 JP JP2021118471A patent/JP7312523B2/ja active Active
- 2021-07-19 US US17/379,534 patent/US12370199B2/en active Active
-
2023
- 2023-05-26 JP JP2023086732A patent/JP2023109959A/ja active Pending
- 2023-05-31 AU AU2023203392A patent/AU2023203392A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019516789A5 (OSRAM) | ||
| JP2019502892A5 (OSRAM) | ||
| JP2016153424A5 (OSRAM) | ||
| JP2016135874A5 (OSRAM) | ||
| JP2014235432A5 (OSRAM) | ||
| JP2014513484A5 (OSRAM) | ||
| JP2014156468A5 (OSRAM) | ||
| CL2017003226A1 (es) | Reguladores nrf2 | |
| JP2014138100A5 (OSRAM) | ||
| JP2014528601A5 (OSRAM) | ||
| JP2015127343A5 (OSRAM) | ||
| JP2016523701A5 (OSRAM) | ||
| JP2018127649A5 (OSRAM) | ||
| CN109843873A (zh) | 炔代杂环化合物、其制备方法及其在医药学上的应用 | |
| JP2015525307A5 (OSRAM) | ||
| JP2017061637A5 (OSRAM) | ||
| JP2016506003A5 (OSRAM) | ||
| JP2019527311A5 (OSRAM) | ||
| JP2014508098A5 (OSRAM) | ||
| JP2015042663A5 (OSRAM) | ||
| JP2013535391A5 (OSRAM) | ||
| CN114929707A (zh) | Eed抑制剂及其制备方法和用途 | |
| JP2021502362A5 (OSRAM) | ||
| CN110382550A (zh) | 抗体偶联物、相关的药物组合物及应用 | |
| ATE457731T1 (de) | Kombination von verbindungen, die bei der behandlung von atemwegserkrankungen verwendet werden können, insbesondere bei chronisch obstruktiver lungenerkrankung (copd) und asthma |